Building on top of EHRs
Traditionally, startups in healthcare have had challenges with distribution. This is not any different from companies in other industries, but innovation is not fully “permissionless” because of regulation, the many stakeholders involved (i.e. government, payers, hospitals/clinics, physicians, caregivers, and patients) with competing incentives, and the power of incumbents that continue to consolidate the market (i.e. […]
Expanding our bio/healthcare thesis
Our first investment in healthcare was five years ago in Figure 1, a platform for viewing and discussing real-world medical cases with healthcare professionals. This investment shaped our original thesis in the category. Figure 1 plays outside the healthcare care system; it’s permissionless innovation, like Yammer or Slack in the enterprise. As we wrote in our Digital […]
Our Approach to Investing in Genomics and Biosciences
It’s hard to believe that it has been a year and a half since we updated our healthcare thesis, as a follow-up to our blog series with Union Square Ventures on the future of healthcare. While we are still spending time on digital health, we have been focusing more on genomics and biosciences as a means to […]
My next chapter of VC: More data!
On the heels of being named principal last week, I am humbled by Boris’s announcement and thrilled to begin leading deals for Version One. While many of you have already worked with me directly or read my thoughts on this blog over the years, I want to take the opportunity to share my goals: what I’m […]
Is it time to rethink the healthcare marketplace model?
It’s been a year since we published our series on digital healthcare which I co-wrote with Jonathan Libov of Union Square Ventures. The reception was overwhelmingly positive (we’re thankful to all of you who gave us feedback) and opened up the floodgates to patients, medical professionals, entrepreneurs, and investors who still reach out to us with their pains, […]